Temporary pacing leads are getting more stage time as doctors try to head off a common heart block complication from TAVR. BioTrace Medical Inc.'s new Tempo lead aims to make temporary pacing more ...
SAN FRANCISCO, April 17, 2025 /PRNewswire/ -- Solo Pace Incorporated, an emerging medical technology company, announced both FDA Clearance and First-In-Human use of their SoloPace Control System for ...
MENLO PARK, Calif.-BioTrace Medical, Inc., the leader in innovative temporary pacing technology, today announced the company’s Tempo® Lead has obtained CE Mark certification in Europe for use in ...
The cardiac pacemaker harmlessly dissolves over the course of 35 days. (Courtesy: Northwestern University) Temporary cardiac pacemakers provide essential pacing for patients with short-term heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results